Similar articles

• A multidisciplinary approach to managing invasive fungal disease. Preface.

  Ullmann AJ, Johnson A. Ullmann AJ, et al. J Antimicrob Chemother. 2013 Nov;68 Suppl 3:i1. J Antimicrob Chemother. 2013. PMID: 24319774 No abstract available.
• A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease.

  Ben-Ami R, Halaburda K, Klyasova G, Metan G, Torosian T, Akova M. Ben-Ami R, et al. J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii25-33. doi: 10.1093/jac/dkt390. J Antimicrob Chemother. 2013. PMID: 24155143
• Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.

  Akan H, Antia VP, Kouba M, Sinkó J, Tănase AD, Vrhovac R, Herbrecht R. Akan H, et al. J Antimicrob Chemother. 2013 Nov;68 Suppl 3:iii5-16. doi: 10.1093/jac/dkt389. J Antimicrob Chemother. 2013. PMID: 24155144
• Antifungal prophylaxis: why, what and how?

  Lyon S. Lyon S. Future Microbiol. 2016;11(1):11-5. doi: 10.2217/fmb.15.129. Epub 2015 Dec 17. Future Microbiol. 2016. PMID: 26674314
• Recent advances in antifungal prevention and treatment.

  Groll AH, Tragiannidis A. Groll AH, et al. Semin Hematol. 2009 Jul;46(3):212-29. doi: 10.1053/j.seminhematol.2009.03.003. Semin Hematol. 2009. PMID: 19549575 Review.